SABSW

SAB BIOTHERAPEUTICS INC

0.0160

+0.0020+14.29%

Opening10:38 09/22 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.0160/0.0140

TODAY RANGE0.0160-0.0160

VOL11.87K

MARKET CAP--

52 WEEK RANGE0.0010-0.1950

AVG VOL (3M)138.91K

% TURNOVER0%

TURNOVER--

P/E (TTM)-0.0256

% RANGE0.00%

EPS(TTM)-0.6250

P/E(FORWARD)-0.0099

P/B0.0062

BVPS2.573

DIVIDEND--

P/S0.2514

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP--

SHARES OUTSTANDING--

NEXT EARNINGS--

FREE FLOAT--

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Dow Jones·4h ago
Press Release: SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of Diabetes
TipRanks·08/10 11:36
Guggenheim Remains a Buy on SAB Biotherapeutics (SABS)
TipRanks·08/07 08:40
Analysts Are Bullish on Top Healthcare Stocks: Genmab (GMAB), Sotera Health (SHC)
TipRanks·08/07 08:10
Analysts Offer Insights on Healthcare Companies: Denali Therapeutics (DNLI) and SAB Biotherapeutics (SABS)
Seeking Alpha·08/06 11:42
SAB Biotherapeutics reports Q2 results
Dow Jones·08/06 11:31
*SAB Biotherapeutics 2Q Loss $22.5M >SABS
Dow Jones·08/06 11:30
*SAB Biotherapeutics: Operational Runway Through 2028 to Support SAFEGUARD Study, PRISE-hATG Study and pre-Comml Activities >SABS
Dow Jones·08/06 11:30
Press Release: SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights
Dow Jones·08/06 11:30
Press Release: SAB BIO Reports Q2 2026 Financial -2-
TipRanks·07/07 12:49
SAB Biotherapeutics advances SAB-142 Type 1 diabetes trial
Dow Jones·06/24 18:59
SAB Biotherapeutics Price Target Announced at $13.00/Share by Barclays
TipRanks·06/24 11:25
SAB Biotherapeutics initiated with an Overweight at Barclays
TipRanks·06/18 22:38
SAB Biotherapeutics Shareholders Back Board and Auditor
Dow Jones·06/17 12:43
SAB Biotherapeutics Price Target Raised to $16.00/Share From $14.00 by Chardan Capital
Dow Jones·06/17 12:43
SAB Biotherapeutics Is Maintained at Buy by Chardan Capital

Same Industry

Name/Symbol

Change%

Price

SABSW

REGN

GridAI Tech

GRDX

+5.59%

3.590

BIONTECH

BNTX

+2.02%

98.00

United Therapeutics Corp.

UTHR

-0.31%

493.10

Vertex Pharmaceuticals Inc

VRTX

-1.55%

508.34

Siga Technologie

SIGA

+2.95%

3.140

Moderna

MRNA

+9.74%

169.04

Charles Riv Labs Intl Inc

CRL

-1.28%

278.06

MEDP

TLPH

ICON plc

ICLR

+3.31%

169.55

CBPO

IQV

MOLN

Arcturus Therape

ARCT

-5.32%

16.03

PRAH

Gilead Sciences Inc

GILD

-0.52%

150.11

Incyte Corp

INCY

-0.53%

124.65

Aptevo Therapeutics Inc

APVO

0.00%

1.840

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.